IP Library Granted Patent US 9,512,465
Granted Patent B2
US 9,512,465 · App. 13/972,365 · Granted Dec 6, 2016

Methods and compositions for labeling nucleic acids

Inventors: Kyle R. Gee (Springfield, OR); Brian Agnew (Eugene, OR); Adrian Salic (Cambridge, MA); Timothy J. Mitchison (Brookline, MA)
Assignees: Life Technologies Corporation; President and Fellows of Harvard College
C12Q1/6806C12Q1/68C12Q1/6816C12Q1/6841G01N33/5011G01N33/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,512,465
App. No.
13/972,365
Granted
Dec 6, 2016
Kind
B2
Abstract

The present invention relates to methods for the labeling of nucleic acid polymers in vitro and in vivo. Certain methods are provided that include a [3+2] cycloaddition between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent attached to a label. Other methods are provided that include a Staudinger ligation between a nucleotide analogue incorporated into a nucleic acid polymer and a reagent comprising a substituted triarylphosphine attached to a label. Such methods do not require fixation and denaturation and therefore can be applied to the labeling of nucleic acid polymers in living cells and in organisms. Also provided are methods for measuring cellular proliferation. In these methods, the amount of label incorporated into the DNA is measured as an indication of cellular proliferation. The methods of the invention can be used in a wide variety of applications including clinical diagnosis of diseases and disorders in which cellular proliferation is involved, toxicity assays, and as a tool for the study of chromosomes' ultrastructures.

Claims (22)

1. A method of differentially labeling DNA, comprising steps of:

contacting a first cell with an effective amount of a first nucleoside analogue that comprises a first azide group such that the nucleoside analogue is incorporated into DNA of the first cell;

contacting a second cell with an effective amount of a second nucleoside analogue that comprises a second azide group such that the nucleoside analogue is incorporated into DNA of the second cell;

contacting the first cell with a first reagent comprising a first label attached to a first substituted triarylphoshine, such that a Staudinger ligation occurs between the first azide and first substituted triarylphosphine; and

contacting the second cell with a second reagent comprising a second label attached to a second substituted triarylphosphine, such that a Staudinger ligation occurs between the second azide and second substituted triarylphosphine.

2. The method of claim 1 , wherein one of the aryl groups of the first triarylphosphine is substituted with a alkyl ester and one of the aryl groups of the second triarylphosphine is substituted with a alkyl ester.

3. The method of claim 2 , wherein the alkyl ester on the first triarylphosphine is in ortho to the phosphorus atom of the first triarylphosphine and the alkyl ester on the second triarylphosphine is in ortho to the phosphorus atom of the second triarylphoshine.

4. The method of claim 1 , wherein the first and second labels are directly detectable.

5. The method of claim 2 , wherein the first label comprises a first fluorescent agent, the second label comprises a second fluorescent agent, and the first and second fluorescent agents produce a dual-color fluorescence upon excitation.

6. The method of claim 1 , wherein the first and second labels are indirectly detectable.

7. The method of claim 6 , wherein the first label comprises a first hapten and the second label comprises a second hapten.

8. A method of differentially labeling DNA, comprising steps of:

administering to a first organism an effective amount of a first nucleoside analogue that comprises a first azide group such that the nucleoside analogue is incorporated into DNA of cells of the first organism;

administering to a second organism an effective amount of a second nucleoside analogue that comprises a second azide group such that the nucleoside analogue is incorporated into DNA of cells of the second organism;

contacting at least one cell of the first organism with a first reagent comprising a first label attached to a first substituted triarylphoshine, such that a Staudinger ligation occurs between the first azide and first substituted triarylphosphine; and

contacting at least one cell of the second organism with a second reagent comprising a second label attached to a second substituted triarylphosphine, such that a Staudinger ligation occurs between the second azide and second substituted triarylphosphine.

9. The method of claim 8 , wherein one of the aryl groups of the first triarylphosphine is substituted with a alkyl ester and one of the aryl groups of the second triarylphosphine is substituted with a alkyl ester.

10. The method of claim 9 , wherein the alkyl ester on the first triarylphosphine is in ortho to the phosphorus atom of the first triarylphosphine and the alkyl ester on the second triarylphosphine is in ortho to the phosphorus atom of the second triarylphoshine.

11. The method of claim 8 , wherein the first and second labels are directly detectable.

12. The method of claim 9 , wherein the first label comprises a first fluorescent agent, the second label comprises a second fluorescent agent, and the first and second fluorescent agents produce a dual-color fluorescence upon excitation.

13. The method of claim 8 , wherein the first and second labels are indirectly detectable.

14. The method of claim 13 , wherein the first label comprises a first hapten and the second label comprises a second hapten.

Assignments (3)
CHANGE OF NAME Recorded Nov 18, 2013
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 031619/0900 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2013
From: AGNEW, BRIAN; GEE, KYLE R.
To: INVITROGEN CORPORATION
Reel/Frame 031613/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2013
From: SALIC, ADRIAN; MITCHISON, TIMOTHY J.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 031613/0909 →
Continuity (4)
Continuation 12785999 · May 24, 2010
Division 11588697 · Oct 27, 2006
Provisional Application 60730745 · Oct 27, 2005
Related Publication 20140065605A1 · Mar 6, 2014